GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.940
+0.270 (5.78%)
At close: Mar 5, 2025, 4:00 PM
5.05
+0.11 (2.13%)
After-hours: Mar 5, 2025, 7:51 PM EST
GoodRx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 792.32 | 750.27 | 766.55 | 745.42 | 550.7 | Upgrade
|
| Revenue Growth (YoY) | 5.61% | -2.12% | 2.83% | 35.36% | 41.85% | Upgrade
|
| Cost of Revenue | 48.48 | 62.43 | 65.08 | 46.72 | 29.59 | Upgrade
|
| Gross Profit | 743.84 | 687.84 | 701.48 | 698.71 | 521.11 | Upgrade
|
| Selling, General & Admin | 462.35 | 450.51 | 464.64 | 524.9 | 714.52 | Upgrade
|
| Research & Development | 121.18 | 126.44 | 143.14 | 125.86 | 61.82 | Upgrade
|
| Other Operating Expenses | 2.47 | - | - | - | - | Upgrade
|
| Operating Expenses | 655.54 | 637.92 | 661.95 | 685.3 | 794.76 | Upgrade
|
| Operating Income | 88.31 | 49.92 | 39.52 | 13.41 | -273.65 | Upgrade
|
| Interest Expense | -52.92 | -56.73 | -34.24 | -23.64 | -27.91 | Upgrade
|
| Interest & Investment Income | 23.27 | 32.17 | 9.27 | 0.06 | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.66 | - | - | - | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | 56 | 25.37 | 14.56 | -10.18 | -301.38 | Upgrade
|
| Merger & Restructuring Charges | -9.46 | -76.93 | -8.43 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -4.01 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -11.3 | - | - | Upgrade
|
| Legal Settlements | -13 | - | - | - | - | Upgrade
|
| Other Unusual Items | -2.08 | - | -18.06 | - | -2.07 | Upgrade
|
| Pretax Income | 31.46 | -55.57 | -23.23 | -10.18 | -303.45 | Upgrade
|
| Income Tax Expense | 15.07 | -46.7 | 9.6 | 15.08 | -9.83 | Upgrade
|
| Net Income | 16.39 | -8.87 | -32.83 | -25.25 | -293.62 | Upgrade
|
| Net Income to Common | 16.39 | -8.87 | -32.83 | -25.25 | -293.62 | Upgrade
|
| Shares Outstanding (Basic) | 386 | 410 | 413 | 410 | 275 | Upgrade
|
| Shares Outstanding (Diluted) | 392 | 410 | 413 | 410 | 275 | Upgrade
|
| Shares Change (YoY) | -4.42% | -0.62% | 0.70% | 49.25% | 18.81% | Upgrade
|
| EPS (Basic) | 0.04 | -0.02 | -0.08 | -0.06 | -1.07 | Upgrade
|
| EPS (Diluted) | 0.04 | -0.02 | -0.08 | -0.06 | -1.07 | Upgrade
|
| Free Cash Flow | 182.65 | 137.25 | 142.81 | 174.21 | 110.79 | Upgrade
|
| Free Cash Flow Per Share | 0.47 | 0.33 | 0.35 | 0.42 | 0.40 | Upgrade
|
| Gross Margin | 93.88% | 91.68% | 91.51% | 93.73% | 94.63% | Upgrade
|
| Operating Margin | 11.15% | 6.65% | 5.16% | 1.80% | -49.69% | Upgrade
|
| Profit Margin | 2.07% | -1.18% | -4.28% | -3.39% | -53.32% | Upgrade
|
| Free Cash Flow Margin | 23.05% | 18.29% | 18.63% | 23.37% | 20.12% | Upgrade
|
| EBITDA | 157.84 | 66.99 | 67.3 | 35.75 | -259.62 | Upgrade
|
| EBITDA Margin | 19.92% | 8.93% | 8.78% | 4.80% | -47.14% | Upgrade
|
| D&A For EBITDA | 69.54 | 17.07 | 27.78 | 22.34 | 14.03 | Upgrade
|
| EBIT | 88.31 | 49.92 | 39.52 | 13.41 | -273.65 | Upgrade
|
| EBIT Margin | 11.14% | 6.65% | 5.16% | 1.80% | -49.69% | Upgrade
|
| Effective Tax Rate | 47.90% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 198.8 | 226.3 | 296.6 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.